Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Molecular Cytogenetics Market, 2022 - Increase in Predictive and Presymptomatic Genetic Testing

This image opens in the lightbox

News provided by

Research and Markets

13 Oct, 2017, 20:00 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, October 13, 2017 /PRNewswire/ --

The "Molecular Cytogenetics Market - Global Opportunity Analysis and Industry Forecasts to 2022" report has been added to Research and Markets' offering.

Global molecular cytogenetics market is expected to reach USD 2,266.4 million by 2022, supported by a CAGR of 11% during the forecast period of 2017 to 2022

The global molecular cytogenetics market is mainly driven by increasing focus on preventive healthcare measures, increasing genetic abnormalities, rising aging population and subsequent increase in various chronic diseases, growing need to reduce mounting healthcare cost, and increasing focus on clinical and research diagnosis.

Moreover, increasing focus on targeted based therapies and growing predictive and presymptomatic genetic testing further provides significant opportunities in this market. However, lack of awareness about emerging diagnosis technologies, high cost of diagnosis, unfavourable reimbursement scenario, and technical limitations and complexities of the equipment inhibits the growth of the market to some extent.

The global molecular cytogenetics market is mainly segmented by technique (fluorescence in situ hybridization, comparative genomic hybridization, in situ hybridization, karyotyping, and banding techniques), by product (instruments, kits and reagents, software, services, and consumable/accessories ), by application (oncology, genetic disorders, personalized medicines, and other), and by end user (pharmaceuticals and biotechnological companies, clinical and diagnostic laboratories, and academic institutes).

The large share of this region is primarily attributed to the increased funding in medical research, stringent drug development regulations which demand molecular cytogenetics techniques, growing aging population and thereby prevalence of various chronic diseases, and direct & indirect financial investments in the pharma biotech companies.

However, Asia-Pacific region possesses lucrative growth potential for the molecular cytogenetic market during the forecast period owing to the increasing demand in China and India, growing population, various technological advancements, growing investment from government & non-government bodies, and growing pharma biotech industry in the region.

Scope of the Report

Market by Technique:

  • Fluorescence In Situ Hybridization
  • Comparative Genomic Hybridization
    • Chromosomal CGH
    • Array CGH
  • In Situ Hybridization
  • Karyotyping
    • Spectral Karyotyping
    • Virtual Karyotyping
  • Banding Techniques
    • G banding
    • Q banding
    • R banding
    • C banding
    • T banding

Market by Product:

  • Instruments
    • Systems
    • Imager and Scanners
  • Kits and Regents
    • Reagents
    • Testing kits
  • Probes
  • Software
  • Services
  • Consumables/Accessories

Market by Application:

  • Oncology
  • Genetic Disorders
  • Personalized Medicines
  • Others

Market by End-user:

  • Pharmaceutical and Biotechnology Companies
  • Clinical and Diagnostic Companies
  • Academic Institutes
  • Others

Key Topics Covered:

1. Introduction
1.1. Market Ecosystem
1.2. Currency And Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2 Drivers
4.2.1. Increasing Focus on Preventive Healthcare Measures
4.2.2. Increasing Genetic Abnormalities
4.2.3. Increasing Aging Population and Subsequent Increase in the Various Chronic Diseases
4.2.4. Growing Need to Reduce Mounting Healthcare Cost
4.2.5. Increasing Focus on Research and Clinical Diagnosis
4.3. Restraints
4.3.1. Lack Of Awareness About Emerging Diagnosis Technologies
4.3.2. High Cost of Diagnosis
4.3.3. Unfavourable Reimbursement Scenario
4.3.4. Technical Limitations and Complexities of The Equipment
4.4. Opportunities
4.4.1. Emerging Economies: China, India, South Korea, and Southeast Asia
4.4.2. Increasing Focus on Targeted Based Therapies
4.4.3. Increase in Predictive and Presymptomatic Genetic Testing
4.5. Trends
4.5.1. Transition From Fluorescence In Situ Hybridization To Array Based Techniques

5. Molecular Cytogenetics Market, by Technique
5.1. Introduction
5.2. Fluorescence In Situ Hybridization
5.3. In Situ Hybridization
5.4. Comparative Genomic Hybridization
5.4.1. Chromosomal-Comparative Genomic Hybridization
5.4.2. Array-Comparative Genomic Hybridization
5.5. Karyotyping
5.5.1. Spectral Karyotyping
5.5.2. Virtual Karyotyping
5.6. Banding Techniques
5.6.1. G Banding
5.6.2. Q Banding
5.6.3. R Banding
5.6.4. C Banding
5.6.5. T Banding

6. Molecular Cytogenetics Market, by Product
6.1. Introduction
6.2. Instruments
6.2.1. Systems
6.2.2. Imagers and Scanners
6.3. Kits and Reagents
6.3.1. Testing Kits
6.3.2. Probes
6.3.3. Reagents
6.4. Software
6.5. Services
6.6. Consumables/Accessories

7. Molecular Cytogenetics Market, b y Application
7.1. Introduction
7.2 Oncology
7.3 Genetic Disorders
7.4 Personalized Medicines
7.5 Other Applications

8. Molecular Cytogenetics Market, by End-User
8.1. Introduction
8.2. Pharmaceutical and Biotechnology Companies
8.3. Clinical and Diagnostic Laboratories
8.4. Academic Institutes
8.5. Others

9. Molecular Cytogenetics Market, by Geography

10. Competitive Landscape
10.1. Introduction
10.2. New Product Launches & Enhancements
10.3. Acquisitions & Mergers
10.4. Expansions
10.5. Agreements, Collaborations, and Partnerships

11. Company Profiles
11.1. Thermo Fisher Scientific
11.2. Abbott Laboratories
11.3. Agilent Technologies
11.4. Perkinelmer
11.5. Bio-Rad Laboratories, Inc.
11.6. Applied Spectral Imaging, Inc.
11.7. Quest Diagnostics
11.8. Roche Holding AG
11.9. Danaher Corporation
11.10. Illumina, Inc.
11.11. Oxford Gene Technology
11.12 Others

12. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/9f4cth/molecular

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.